Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
6
×
san francisco top stories
biotech
boston blog main
new york blog main
new york top stories
boston top stories
clinical trials
national top stories
deals
europe blog main
europe top stories
national
startups
abbvie
alzheimer's disease
amgen
biotech ipos
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
chronic kidney disease
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
investing
medical device
merck
moderna
pfizer
raleigh-durham blog main
raleigh-durham top stories
renaissance capital
What
week
6
×
companies
life
science
street
wall
announced
bio
biotech
ceo
debut
drug
ipo
medicine
moves
roundup
way
welcomed
aces
acquisitions
area
arrival
based
bay
big
biggest
biopsy
black
blood
boost
build
buildout
buy
cancer
cholesterol
close
company
company’s
continue
daniel
Language
unset
6
×
Current search:
week
×
unset
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
